nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisplatin—germ cell cancer—malignant glioma	0.247	0.52	CtDrD
Cisplatin—peripheral nervous system neoplasm—malignant glioma	0.228	0.48	CtDrD
Cisplatin—SOD1—malignant glioma	0.114	0.294	CbGaD
Cisplatin—GSTT1—malignant glioma	0.0843	0.217	CbGaD
Cisplatin—GSTP1—malignant glioma	0.0667	0.172	CbGaD
Cisplatin—CYP2B6—malignant glioma	0.0561	0.144	CbGaD
Cisplatin—BCHE—malignant glioma	0.0458	0.118	CbGaD
Cisplatin—PTGS2—malignant glioma	0.0211	0.0543	CbGaD
Cisplatin—Ocular toxicity—Carmustine—malignant glioma	0.00341	0.0748	CcSEcCtD
Cisplatin—Metastatic neoplasm—Temozolomide—malignant glioma	0.00232	0.0511	CcSEcCtD
Cisplatin—Pulmonary toxicity—Carmustine—malignant glioma	0.00203	0.0446	CcSEcCtD
Cisplatin—Fibrosis—Carmustine—malignant glioma	0.00161	0.0354	CcSEcCtD
Cisplatin—Acute leukaemia—Carmustine—malignant glioma	0.00161	0.0354	CcSEcCtD
Cisplatin—Acute leukaemia—Temozolomide—malignant glioma	0.00156	0.0342	CcSEcCtD
Cisplatin—Nephrotoxicity—Carmustine—malignant glioma	0.00145	0.0318	CcSEcCtD
Cisplatin—ATP7A—endothelium—malignant glioma	0.00133	0.0439	CbGeAlD
Cisplatin—Skin necrosis—Carmustine—malignant glioma	0.00132	0.029	CcSEcCtD
Cisplatin—ATP7A—blood vessel—malignant glioma	0.00123	0.0405	CbGeAlD
Cisplatin—GSTM1—blood vessel—malignant glioma	0.00102	0.0337	CbGeAlD
Cisplatin—Myelosuppression—Carmustine—malignant glioma	0.000984	0.0216	CcSEcCtD
Cisplatin—Myelosuppression—Temozolomide—malignant glioma	0.000951	0.0209	CcSEcCtD
Cisplatin—Nephropathy toxic—Carmustine—malignant glioma	0.000803	0.0176	CcSEcCtD
Cisplatin—Febrile neutropenia—Carmustine—malignant glioma	0.000767	0.0168	CcSEcCtD
Cisplatin—Febrile neutropenia—Temozolomide—malignant glioma	0.000741	0.0163	CcSEcCtD
Cisplatin—MPO—endothelium—malignant glioma	0.000714	0.0236	CbGeAlD
Cisplatin—MT2A—telencephalon—malignant glioma	0.000688	0.0227	CbGeAlD
Cisplatin—SLC31A2—telencephalon—malignant glioma	0.000676	0.0223	CbGeAlD
Cisplatin—MPO—blood vessel—malignant glioma	0.000659	0.0217	CbGeAlD
Cisplatin—Hepatotoxicity—Carmustine—malignant glioma	0.000597	0.0131	CcSEcCtD
Cisplatin—ABCC6—retina—malignant glioma	0.000594	0.0196	CbGeAlD
Cisplatin—Necrosis—Carmustine—malignant glioma	0.000588	0.0129	CcSEcCtD
Cisplatin—Abscess—Carmustine—malignant glioma	0.000583	0.0128	CcSEcCtD
Cisplatin—Hepatotoxicity—Temozolomide—malignant glioma	0.000577	0.0127	CcSEcCtD
Cisplatin—SLC31A2—medulla oblongata—malignant glioma	0.000531	0.0175	CbGeAlD
Cisplatin—Liver injury—Temozolomide—malignant glioma	0.00053	0.0116	CcSEcCtD
Cisplatin—Extravasation—Carmustine—malignant glioma	0.000529	0.0116	CcSEcCtD
Cisplatin—SOD1—telencephalon—malignant glioma	0.000522	0.0172	CbGeAlD
Cisplatin—SLC31A2—midbrain—malignant glioma	0.000486	0.016	CbGeAlD
Cisplatin—MT2A—spinal cord—malignant glioma	0.000482	0.0159	CbGeAlD
Cisplatin—SLC31A2—spinal cord—malignant glioma	0.000474	0.0156	CbGeAlD
Cisplatin—Hearing impaired—Temozolomide—malignant glioma	0.000468	0.0103	CcSEcCtD
Cisplatin—ATP7A—medulla oblongata—malignant glioma	0.000468	0.0154	CbGeAlD
Cisplatin—MT1A—cerebellum—malignant glioma	0.000459	0.0151	CbGeAlD
Cisplatin—Skin exfoliation—Carmustine—malignant glioma	0.00044	0.00967	CcSEcCtD
Cisplatin—Neuropathy—Carmustine—malignant glioma	0.000433	0.00951	CcSEcCtD
Cisplatin—ATP7A—midbrain—malignant glioma	0.000428	0.0141	CbGeAlD
Cisplatin—Skin exfoliation—Temozolomide—malignant glioma	0.000426	0.00934	CcSEcCtD
Cisplatin—ATP7B—central nervous system—malignant glioma	0.000421	0.0139	CbGeAlD
Cisplatin—Neuropathy—Temozolomide—malignant glioma	0.000418	0.00919	CcSEcCtD
Cisplatin—ATP7A—spinal cord—malignant glioma	0.000417	0.0138	CbGeAlD
Cisplatin—ATP7B—cerebellum—malignant glioma	0.000411	0.0136	CbGeAlD
Cisplatin—SOD1—medulla oblongata—malignant glioma	0.00041	0.0135	CbGeAlD
Cisplatin—ABCC5—retina—malignant glioma	0.000404	0.0133	CbGeAlD
Cisplatin—SLC31A1—medulla oblongata—malignant glioma	0.000399	0.0132	CbGeAlD
Cisplatin—MT2A—central nervous system—malignant glioma	0.000391	0.0129	CbGeAlD
Cisplatin—Phlebitis—Carmustine—malignant glioma	0.000389	0.00853	CcSEcCtD
Cisplatin—SLC31A2—central nervous system—malignant glioma	0.000384	0.0127	CbGeAlD
Cisplatin—GSTP1—embryo—malignant glioma	0.000382	0.0126	CbGeAlD
Cisplatin—NQO1—retina—malignant glioma	0.000378	0.0125	CbGeAlD
Cisplatin—SLC31A2—cerebellum—malignant glioma	0.000376	0.0124	CbGeAlD
Cisplatin—SOD1—midbrain—malignant glioma	0.000375	0.0124	CbGeAlD
Cisplatin—MT1A—brain—malignant glioma	0.000373	0.0123	CbGeAlD
Cisplatin—ABCC5—telencephalon—malignant glioma	0.000372	0.0123	CbGeAlD
Cisplatin—SOD1—spinal cord—malignant glioma	0.000365	0.0121	CbGeAlD
Cisplatin—SLC31A1—midbrain—malignant glioma	0.000365	0.012	CbGeAlD
Cisplatin—Deafness—Temozolomide—malignant glioma	0.000362	0.00794	CcSEcCtD
Cisplatin—Amnesia—Carmustine—malignant glioma	0.000356	0.00783	CcSEcCtD
Cisplatin—SLC31A1—spinal cord—malignant glioma	0.000356	0.0117	CbGeAlD
Cisplatin—Nasal congestion—Temozolomide—malignant glioma	0.000355	0.0078	CcSEcCtD
Cisplatin—NQO1—telencephalon—malignant glioma	0.000348	0.0115	CbGeAlD
Cisplatin—Amnesia—Temozolomide—malignant glioma	0.000344	0.00756	CcSEcCtD
Cisplatin—GSTP1—retina—malignant glioma	0.000338	0.0111	CbGeAlD
Cisplatin—Hyponatraemia—Carmustine—malignant glioma	0.000336	0.00738	CcSEcCtD
Cisplatin—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.000335	0.00735	CcSEcCtD
Cisplatin—ATP7B—brain—malignant glioma	0.000334	0.011	CbGeAlD
Cisplatin—PTGS2—endothelium—malignant glioma	0.000324	0.0107	CbGeAlD
Cisplatin—Face oedema—Carmustine—malignant glioma	0.000323	0.0071	CcSEcCtD
Cisplatin—Face oedema—Temozolomide—malignant glioma	0.000312	0.00686	CcSEcCtD
Cisplatin—GSTP1—telencephalon—malignant glioma	0.000311	0.0102	CbGeAlD
Cisplatin—MT2A—brain—malignant glioma	0.000311	0.0102	CbGeAlD
Cisplatin—SLC31A2—brain—malignant glioma	0.000305	0.0101	CbGeAlD
Cisplatin—Hypokalaemia—Carmustine—malignant glioma	0.000305	0.00669	CcSEcCtD
Cisplatin—Dehydration—Temozolomide—malignant glioma	0.000301	0.00661	CcSEcCtD
Cisplatin—PTGS2—blood vessel—malignant glioma	0.000299	0.00986	CbGeAlD
Cisplatin—Hypokalaemia—Temozolomide—malignant glioma	0.000294	0.00647	CcSEcCtD
Cisplatin—Breast disorder—Temozolomide—malignant glioma	0.000292	0.00642	CcSEcCtD
Cisplatin—ABCC5—medulla oblongata—malignant glioma	0.000292	0.00963	CbGeAlD
Cisplatin—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.000291	0.0064	CcSEcCtD
Cisplatin—SOD1—cerebellum—malignant glioma	0.00029	0.00956	CbGeAlD
Cisplatin—SLC31A1—central nervous system—malignant glioma	0.000289	0.00953	CbGeAlD
Cisplatin—SLC31A1—cerebellum—malignant glioma	0.000282	0.00931	CbGeAlD
Cisplatin—GSTM1—central nervous system—malignant glioma	0.000282	0.0093	CbGeAlD
Cisplatin—GSTM1—cerebellum—malignant glioma	0.000276	0.00909	CbGeAlD
Cisplatin—Pancytopenia—Carmustine—malignant glioma	0.000275	0.00603	CcSEcCtD
Cisplatin—NQO1—medulla oblongata—malignant glioma	0.000273	0.00901	CbGeAlD
Cisplatin—Sweating increased—Temozolomide—malignant glioma	0.000272	0.00598	CcSEcCtD
Cisplatin—ATP7A—brain—malignant glioma	0.000269	0.00887	CbGeAlD
Cisplatin—ABCC5—midbrain—malignant glioma	0.000267	0.0088	CbGeAlD
Cisplatin—Pancytopenia—Temozolomide—malignant glioma	0.000266	0.00583	CcSEcCtD
Cisplatin—Renal failure—Carmustine—malignant glioma	0.000254	0.00557	CcSEcCtD
Cisplatin—Neuropathy peripheral—Carmustine—malignant glioma	0.000253	0.00555	CcSEcCtD
Cisplatin—Stomatitis—Carmustine—malignant glioma	0.000251	0.00552	CcSEcCtD
Cisplatin—NQO1—midbrain—malignant glioma	0.00025	0.00824	CbGeAlD
Cisplatin—Neuropathy peripheral—Temozolomide—malignant glioma	0.000244	0.00537	CcSEcCtD
Cisplatin—GSTP1—medulla oblongata—malignant glioma	0.000244	0.00805	CbGeAlD
Cisplatin—NQO1—spinal cord—malignant glioma	0.000244	0.00804	CbGeAlD
Cisplatin—Stomatitis—Temozolomide—malignant glioma	0.000243	0.00534	CcSEcCtD
Cisplatin—Hepatobiliary disease—Temozolomide—malignant glioma	0.000236	0.00518	CcSEcCtD
Cisplatin—SOD1—brain—malignant glioma	0.000235	0.00776	CbGeAlD
Cisplatin—SLC31A1—brain—malignant glioma	0.000229	0.00756	CbGeAlD
Cisplatin—Connective tissue disorder—Carmustine—malignant glioma	0.000228	0.005	CcSEcCtD
Cisplatin—MPO—spinal cord—malignant glioma	0.000224	0.00739	CbGeAlD
Cisplatin—GSTM1—brain—malignant glioma	0.000224	0.00738	CbGeAlD
Cisplatin—Visual impairment—Carmustine—malignant glioma	0.000223	0.0049	CcSEcCtD
Cisplatin—GSTP1—midbrain—malignant glioma	0.000223	0.00736	CbGeAlD
Cisplatin—Urinary tract disorder—Temozolomide—malignant glioma	0.000221	0.00485	CcSEcCtD
Cisplatin—Connective tissue disorder—Temozolomide—malignant glioma	0.00022	0.00483	CcSEcCtD
Cisplatin—Urethral disorder—Temozolomide—malignant glioma	0.000219	0.00482	CcSEcCtD
Cisplatin—GSTP1—spinal cord—malignant glioma	0.000218	0.00718	CbGeAlD
Cisplatin—Eye disorder—Carmustine—malignant glioma	0.000216	0.00475	CcSEcCtD
Cisplatin—Visual impairment—Temozolomide—malignant glioma	0.000216	0.00474	CcSEcCtD
Cisplatin—Flushing—Carmustine—malignant glioma	0.000215	0.00472	CcSEcCtD
Cisplatin—BCHE—brainstem—malignant glioma	0.000212	0.00699	CbGeAlD
Cisplatin—Eye disorder—Temozolomide—malignant glioma	0.000209	0.00459	CcSEcCtD
Cisplatin—Tinnitus—Temozolomide—malignant glioma	0.000209	0.00458	CcSEcCtD
Cisplatin—Cardiac disorder—Temozolomide—malignant glioma	0.000208	0.00456	CcSEcCtD
Cisplatin—Flushing—Temozolomide—malignant glioma	0.000208	0.00456	CcSEcCtD
Cisplatin—Arrhythmia—Carmustine—malignant glioma	0.000207	0.00454	CcSEcCtD
Cisplatin—ABCC5—cerebellum—malignant glioma	0.000206	0.00681	CbGeAlD
Cisplatin—Alopecia—Carmustine—malignant glioma	0.000205	0.00449	CcSEcCtD
Cisplatin—Immune system disorder—Temozolomide—malignant glioma	0.000202	0.00444	CcSEcCtD
Cisplatin—Mediastinal disorder—Temozolomide—malignant glioma	0.000202	0.00443	CcSEcCtD
Cisplatin—Malnutrition—Carmustine—malignant glioma	0.000202	0.00443	CcSEcCtD
Cisplatin—Erythema—Carmustine—malignant glioma	0.000202	0.00443	CcSEcCtD
Cisplatin—Alopecia—Temozolomide—malignant glioma	0.000198	0.00434	CcSEcCtD
Cisplatin—NQO1—central nervous system—malignant glioma	0.000198	0.00652	CbGeAlD
Cisplatin—Erythema—Temozolomide—malignant glioma	0.000195	0.00428	CcSEcCtD
Cisplatin—Malnutrition—Temozolomide—malignant glioma	0.000195	0.00428	CcSEcCtD
Cisplatin—NQO1—cerebellum—malignant glioma	0.000193	0.00637	CbGeAlD
Cisplatin—Vision blurred—Carmustine—malignant glioma	0.00019	0.00417	CcSEcCtD
Cisplatin—Tremor—Carmustine—malignant glioma	0.000189	0.00415	CcSEcCtD
Cisplatin—BCHE—telencephalon—malignant glioma	0.000188	0.00621	CbGeAlD
Cisplatin—Anaemia—Carmustine—malignant glioma	0.000186	0.00409	CcSEcCtD
Cisplatin—ABCB1—blood vessel—malignant glioma	0.000185	0.0061	CbGeAlD
Cisplatin—Vision blurred—Temozolomide—malignant glioma	0.000184	0.00403	CcSEcCtD
Cisplatin—Tremor—Temozolomide—malignant glioma	0.000183	0.00401	CcSEcCtD
Cisplatin—ABCG2—telencephalon—malignant glioma	0.000182	0.006	CbGeAlD
Cisplatin—MPO—central nervous system—malignant glioma	0.000182	0.00599	CbGeAlD
Cisplatin—Ill-defined disorder—Temozolomide—malignant glioma	0.000181	0.00397	CcSEcCtD
Cisplatin—Leukopenia—Carmustine—malignant glioma	0.00018	0.00396	CcSEcCtD
Cisplatin—Anaemia—Temozolomide—malignant glioma	0.00018	0.00395	CcSEcCtD
Cisplatin—PTGS2—embryo—malignant glioma	0.000178	0.00588	CbGeAlD
Cisplatin—ABCC3—central nervous system—malignant glioma	0.000177	0.00585	CbGeAlD
Cisplatin—GSTP1—central nervous system—malignant glioma	0.000177	0.00583	CbGeAlD
Cisplatin—Malaise—Temozolomide—malignant glioma	0.000176	0.00386	CcSEcCtD
Cisplatin—Convulsion—Carmustine—malignant glioma	0.000175	0.00384	CcSEcCtD
Cisplatin—Leukopenia—Temozolomide—malignant glioma	0.000174	0.00383	CcSEcCtD
Cisplatin—GSTP1—cerebellum—malignant glioma	0.000173	0.00569	CbGeAlD
Cisplatin—Myalgia—Carmustine—malignant glioma	0.000172	0.00377	CcSEcCtD
Cisplatin—Anxiety—Carmustine—malignant glioma	0.000171	0.00376	CcSEcCtD
Cisplatin—Convulsion—Temozolomide—malignant glioma	0.000169	0.00371	CcSEcCtD
Cisplatin—ABCC5—brain—malignant glioma	0.000168	0.00553	CbGeAlD
Cisplatin—Myalgia—Temozolomide—malignant glioma	0.000166	0.00364	CcSEcCtD
Cisplatin—Anxiety—Temozolomide—malignant glioma	0.000165	0.00363	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000165	0.00362	CcSEcCtD
Cisplatin—Oedema—Carmustine—malignant glioma	0.000165	0.00361	CcSEcCtD
Cisplatin—Discomfort—Temozolomide—malignant glioma	0.000164	0.0036	CcSEcCtD
Cisplatin—Infection—Carmustine—malignant glioma	0.000163	0.00359	CcSEcCtD
Cisplatin—Thrombocytopenia—Carmustine—malignant glioma	0.000161	0.00354	CcSEcCtD
Cisplatin—Tachycardia—Carmustine—malignant glioma	0.000161	0.00353	CcSEcCtD
Cisplatin—Anaphylactic shock—Temozolomide—malignant glioma	0.000159	0.00349	CcSEcCtD
Cisplatin—Oedema—Temozolomide—malignant glioma	0.000159	0.00349	CcSEcCtD
Cisplatin—Infection—Temozolomide—malignant glioma	0.000158	0.00347	CcSEcCtD
Cisplatin—NQO1—brain—malignant glioma	0.000157	0.00517	CbGeAlD
Cisplatin—Anorexia—Carmustine—malignant glioma	0.000157	0.00344	CcSEcCtD
Cisplatin—Nervous system disorder—Temozolomide—malignant glioma	0.000156	0.00342	CcSEcCtD
Cisplatin—Thrombocytopenia—Temozolomide—malignant glioma	0.000156	0.00342	CcSEcCtD
Cisplatin—Skin disorder—Temozolomide—malignant glioma	0.000154	0.00339	CcSEcCtD
Cisplatin—Hypotension—Carmustine—malignant glioma	0.000154	0.00338	CcSEcCtD
Cisplatin—Hyperhidrosis—Temozolomide—malignant glioma	0.000154	0.00338	CcSEcCtD
Cisplatin—Anorexia—Temozolomide—malignant glioma	0.000152	0.00333	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00015	0.00329	CcSEcCtD
Cisplatin—BCHE—medulla oblongata—malignant glioma	0.000148	0.00488	CbGeAlD
Cisplatin—Paraesthesia—Carmustine—malignant glioma	0.000148	0.00324	CcSEcCtD
Cisplatin—Dyspnoea—Carmustine—malignant glioma	0.000147	0.00322	CcSEcCtD
Cisplatin—PTGS2—telencephalon—malignant glioma	0.000145	0.00478	CbGeAlD
Cisplatin—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000145	0.00318	CcSEcCtD
Cisplatin—MPO—brain—malignant glioma	0.000144	0.00476	CbGeAlD
Cisplatin—Decreased appetite—Carmustine—malignant glioma	0.000143	0.00314	CcSEcCtD
Cisplatin—ABCG2—medulla oblongata—malignant glioma	0.000143	0.00471	CbGeAlD
Cisplatin—Paraesthesia—Temozolomide—malignant glioma	0.000143	0.00314	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Carmustine—malignant glioma	0.000142	0.00312	CcSEcCtD
Cisplatin—Dyspnoea—Temozolomide—malignant glioma	0.000142	0.00311	CcSEcCtD
Cisplatin—ABCC3—brain—malignant glioma	0.000141	0.00464	CbGeAlD
Cisplatin—Pain—Carmustine—malignant glioma	0.000141	0.00309	CcSEcCtD
Cisplatin—GSTP1—brain—malignant glioma	0.00014	0.00462	CbGeAlD
Cisplatin—Decreased appetite—Temozolomide—malignant glioma	0.000138	0.00304	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000137	0.00301	CcSEcCtD
Cisplatin—Pain—Temozolomide—malignant glioma	0.000136	0.00299	CcSEcCtD
Cisplatin—Feeling abnormal—Carmustine—malignant glioma	0.000136	0.00298	CcSEcCtD
Cisplatin—BCHE—midbrain—malignant glioma	0.000135	0.00446	CbGeAlD
Cisplatin—BCHE—spinal cord—malignant glioma	0.000132	0.00435	CbGeAlD
Cisplatin—Feeling abnormal—Temozolomide—malignant glioma	0.000131	0.00288	CcSEcCtD
Cisplatin—ABCG2—midbrain—malignant glioma	0.000131	0.00431	CbGeAlD
Cisplatin—Body temperature increased—Carmustine—malignant glioma	0.00013	0.00286	CcSEcCtD
Cisplatin—ABCG2—spinal cord—malignant glioma	0.000127	0.0042	CbGeAlD
Cisplatin—Body temperature increased—Temozolomide—malignant glioma	0.000126	0.00276	CcSEcCtD
Cisplatin—Hypersensitivity—Carmustine—malignant glioma	0.000121	0.00266	CcSEcCtD
Cisplatin—Asthenia—Carmustine—malignant glioma	0.000118	0.00259	CcSEcCtD
Cisplatin—Hypersensitivity—Temozolomide—malignant glioma	0.000117	0.00257	CcSEcCtD
Cisplatin—Asthenia—Temozolomide—malignant glioma	0.000114	0.00251	CcSEcCtD
Cisplatin—PTGS2—medulla oblongata—malignant glioma	0.000114	0.00376	CbGeAlD
Cisplatin—Diarrhoea—Carmustine—malignant glioma	0.000113	0.00247	CcSEcCtD
Cisplatin—ABCB1—embryo—malignant glioma	0.00011	0.00364	CbGeAlD
Cisplatin—Diarrhoea—Temozolomide—malignant glioma	0.000109	0.00239	CcSEcCtD
Cisplatin—BCHE—central nervous system—malignant glioma	0.000107	0.00353	CbGeAlD
Cisplatin—Vomiting—Carmustine—malignant glioma	0.000105	0.0023	CcSEcCtD
Cisplatin—BCHE—cerebellum—malignant glioma	0.000105	0.00345	CbGeAlD
Cisplatin—PTGS2—midbrain—malignant glioma	0.000104	0.00343	CbGeAlD
Cisplatin—Rash—Carmustine—malignant glioma	0.000104	0.00228	CcSEcCtD
Cisplatin—Dermatitis—Carmustine—malignant glioma	0.000104	0.00228	CcSEcCtD
Cisplatin—PTGS2—spinal cord—malignant glioma	0.000102	0.00335	CbGeAlD
Cisplatin—Vomiting—Temozolomide—malignant glioma	0.000101	0.00222	CcSEcCtD
Cisplatin—ABCG2—cerebellum—malignant glioma	0.000101	0.00333	CbGeAlD
Cisplatin—Rash—Temozolomide—malignant glioma	0.0001	0.0022	CcSEcCtD
Cisplatin—Dermatitis—Temozolomide—malignant glioma	0.0001	0.0022	CcSEcCtD
Cisplatin—Nausea—Carmustine—malignant glioma	9.77e-05	0.00215	CcSEcCtD
Cisplatin—ABCB1—retina—malignant glioma	9.75e-05	0.00321	CbGeAlD
Cisplatin—CYP2B6—central nervous system—malignant glioma	9.53e-05	0.00314	CbGeAlD
Cisplatin—Nausea—Temozolomide—malignant glioma	9.45e-05	0.00207	CcSEcCtD
Cisplatin—ABCB1—telencephalon—malignant glioma	8.97e-05	0.00296	CbGeAlD
Cisplatin—BCHE—brain—malignant glioma	8.49e-05	0.0028	CbGeAlD
Cisplatin—PTGS2—central nervous system—malignant glioma	8.24e-05	0.00272	CbGeAlD
Cisplatin—ABCG2—brain—malignant glioma	8.2e-05	0.00271	CbGeAlD
Cisplatin—PTGS2—cerebellum—malignant glioma	8.05e-05	0.00266	CbGeAlD
Cisplatin—CYP2B6—brain—malignant glioma	7.57e-05	0.0025	CbGeAlD
Cisplatin—ABCB1—medulla oblongata—malignant glioma	7.04e-05	0.00232	CbGeAlD
Cisplatin—PTGS2—brain—malignant glioma	6.54e-05	0.00216	CbGeAlD
Cisplatin—ABCB1—midbrain—malignant glioma	6.44e-05	0.00212	CbGeAlD
Cisplatin—ABCB1—spinal cord—malignant glioma	6.28e-05	0.00207	CbGeAlD
Cisplatin—ABCB1—central nervous system—malignant glioma	5.1e-05	0.00168	CbGeAlD
Cisplatin—ABCB1—cerebellum—malignant glioma	4.98e-05	0.00164	CbGeAlD
Cisplatin—ABCB1—brain—malignant glioma	4.05e-05	0.00133	CbGeAlD
Cisplatin—ABCC5—Disease—FGF2—malignant glioma	4.45e-06	7.24e-05	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—PIK3CG—malignant glioma	4.43e-06	7.21e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PTGS1—malignant glioma	4.41e-06	7.18e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—SPHK1—malignant glioma	4.4e-06	7.17e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—NCOR1—malignant glioma	4.4e-06	7.16e-05	CbGpPWpGaD
Cisplatin—ABCC2—Transmembrane transport of small molecules—RAF1—malignant glioma	4.34e-06	7.06e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	4.33e-06	7.05e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—CYP2C18—malignant glioma	4.31e-06	7.02e-05	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	4.31e-06	7.02e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	4.29e-06	6.99e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—MMP2—malignant glioma	4.29e-06	6.98e-05	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—PPARG—malignant glioma	4.28e-06	6.96e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	4.25e-06	6.92e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	4.23e-06	6.89e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—CAV1—malignant glioma	4.22e-06	6.86e-05	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	4.17e-06	6.79e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—MDM2—malignant glioma	4.17e-06	6.78e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—RAF1—malignant glioma	4.15e-06	6.76e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—BCHE—malignant glioma	4.15e-06	6.75e-05	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—PTEN—malignant glioma	4.12e-06	6.7e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—ERBB2—malignant glioma	4.11e-06	6.68e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—BCHE—malignant glioma	4.1e-06	6.68e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—SLC5A5—malignant glioma	4.1e-06	6.67e-05	CbGpPWpGaD
Cisplatin—XDH—Metabolism—PIK3CD—malignant glioma	4.06e-06	6.61e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—SLC5A5—malignant glioma	4.05e-06	6.6e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—PIK3CB—malignant glioma	4.05e-06	6.6e-05	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—PIK3CB—malignant glioma	4.05e-06	6.59e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.03e-06	6.56e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—H3F3A—malignant glioma	4.02e-06	6.55e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—PTGS2—malignant glioma	4.02e-06	6.53e-05	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—PTGS2—malignant glioma	4.01e-06	6.53e-05	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—PIK3CB—malignant glioma	3.95e-06	6.42e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	3.91e-06	6.37e-05	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—PTGS2—malignant glioma	3.91e-06	6.36e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—IDH2—malignant glioma	3.9e-06	6.35e-05	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—PIK3CD—malignant glioma	3.89e-06	6.34e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	3.86e-06	6.28e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PIK3CG—malignant glioma	3.84e-06	6.25e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—JAG1—malignant glioma	3.79e-06	6.17e-05	CbGpPWpGaD
Cisplatin—ABCG2—Transmembrane transport of small molecules—RAF1—malignant glioma	3.77e-06	6.14e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Transmembrane transport of small molecules—RAF1—malignant glioma	3.73e-06	6.08e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	3.72e-06	6.06e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—FBXW7—malignant glioma	3.72e-06	6.05e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	3.71e-06	6.04e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PPARG—malignant glioma	3.71e-06	6.03e-05	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—AKT1—malignant glioma	3.68e-06	5.99e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CYP2B6—malignant glioma	3.67e-06	5.97e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—GSTP1—malignant glioma	3.66e-06	5.95e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—IDH2—malignant glioma	3.65e-06	5.93e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—GSTT1—malignant glioma	3.63e-06	5.91e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	3.6e-06	5.86e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—CAV1—malignant glioma	3.59e-06	5.83e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—CXCL8—malignant glioma	3.56e-06	5.8e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—CAT—malignant glioma	3.56e-06	5.79e-05	CbGpPWpGaD
Cisplatin—XDH—Metabolism—PIK3CB—malignant glioma	3.54e-06	5.76e-05	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	3.52e-06	5.73e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	3.52e-06	5.73e-05	CbGpPWpGaD
Cisplatin—XDH—Metabolism—PTGS2—malignant glioma	3.51e-06	5.71e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—PTEN—malignant glioma	3.5e-06	5.7e-05	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—PTEN—malignant glioma	3.5e-06	5.7e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—GSTT1—malignant glioma	3.49e-06	5.68e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	3.44e-06	5.6e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CYP2B6—malignant glioma	3.43e-06	5.58e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.43e-06	5.57e-05	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—PTEN—malignant glioma	3.41e-06	5.55e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PTGS1—malignant glioma	3.4e-06	5.54e-05	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—PIK3CB—malignant glioma	3.39e-06	5.52e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	3.39e-06	5.52e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PIK3CD—malignant glioma	3.38e-06	5.49e-05	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—PTGS2—malignant glioma	3.36e-06	5.47e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—NCOR1—malignant glioma	3.36e-06	5.47e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—IDH1—malignant glioma	3.36e-06	5.46e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	3.36e-06	5.46e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	3.33e-06	5.42e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—GSTP1—malignant glioma	3.3e-06	5.37e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PTGS1—malignant glioma	3.27e-06	5.32e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—GSTP1—malignant glioma	3.27e-06	5.31e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PIK3CG—malignant glioma	3.27e-06	5.31e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—SPHK1—malignant glioma	3.25e-06	5.29e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—CAT—malignant glioma	3.21e-06	5.23e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CYP2C18—malignant glioma	3.18e-06	5.18e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—CAT—malignant glioma	3.18e-06	5.17e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—BCHE—malignant glioma	3.16e-06	5.15e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PPARG—malignant glioma	3.15e-06	5.13e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—IDH1—malignant glioma	3.14e-06	5.1e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—STAT3—malignant glioma	3.13e-06	5.1e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—SLC5A5—malignant glioma	3.12e-06	5.08e-05	CbGpPWpGaD
Cisplatin—XDH—Metabolism—PTEN—malignant glioma	3.06e-06	4.98e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	3.06e-06	4.98e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—BCHE—malignant glioma	3.04e-06	4.95e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—SPHK1—malignant glioma	3.03e-06	4.94e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—NCOR1—malignant glioma	3.03e-06	4.93e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—SLC5A5—malignant glioma	3e-06	4.89e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—NCOR1—malignant glioma	3e-06	4.88e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CYP2C18—malignant glioma	2.97e-06	4.84e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	2.96e-06	4.81e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.95e-06	4.81e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PIK3CB—malignant glioma	2.94e-06	4.79e-05	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—PTEN—malignant glioma	2.93e-06	4.77e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PTGS2—malignant glioma	2.92e-06	4.75e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CDKN2B—malignant glioma	2.91e-06	4.74e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—MYC—malignant glioma	2.91e-06	4.74e-05	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—PIK3CA—malignant glioma	2.9e-06	4.73e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PIK3CD—malignant glioma	2.87e-06	4.67e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—EGFR—malignant glioma	2.85e-06	4.63e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.8e-06	4.56e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—HES1—malignant glioma	2.78e-06	4.52e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—NCOR1—malignant glioma	2.76e-06	4.49e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—CAV1—malignant glioma	2.74e-06	4.46e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—KRAS—malignant glioma	2.69e-06	4.38e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PDGFRA—malignant glioma	2.64e-06	4.3e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.62e-06	4.26e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—GSTT1—malignant glioma	2.57e-06	4.19e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.55e-06	4.16e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.55e-06	4.15e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PTEN—malignant glioma	2.54e-06	4.14e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—GSTP1—malignant glioma	2.52e-06	4.1e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PIK3CB—malignant glioma	2.5e-06	4.07e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	2.5e-06	4.06e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PIK3CG—malignant glioma	2.5e-06	4.06e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PTGS2—malignant glioma	2.48e-06	4.03e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—CAV1—malignant glioma	2.47e-06	4.02e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—PIK3CA—malignant glioma	2.47e-06	4.02e-05	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—PIK3CA—malignant glioma	2.47e-06	4.02e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.46e-06	4.01e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—CAT—malignant glioma	2.45e-06	3.99e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—CAV1—malignant glioma	2.45e-06	3.98e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—TERT—malignant glioma	2.43e-06	3.96e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—HLA-A—malignant glioma	2.43e-06	3.96e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—GSTP1—malignant glioma	2.42e-06	3.94e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PTGS1—malignant glioma	2.41e-06	3.92e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PPARG—malignant glioma	2.41e-06	3.92e-05	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—PIK3CA—malignant glioma	2.41e-06	3.92e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GSTT1—malignant glioma	2.4e-06	3.91e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PDGFB—malignant glioma	2.38e-06	3.87e-05	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—AKT1—malignant glioma	2.37e-06	3.86e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—FGFR1—malignant glioma	2.36e-06	3.85e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—CAT—malignant glioma	2.35e-06	3.83e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—HIF1A—malignant glioma	2.33e-06	3.79e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—NCOR1—malignant glioma	2.31e-06	3.76e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PTGS1—malignant glioma	2.25e-06	3.67e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PIK3CG—malignant glioma	2.25e-06	3.66e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CAV1—malignant glioma	2.25e-06	3.66e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.24e-06	3.65e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—BCHE—malignant glioma	2.24e-06	3.65e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PIK3CG—malignant glioma	2.23e-06	3.63e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—NCOR1—malignant glioma	2.22e-06	3.62e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—SLC5A5—malignant glioma	2.21e-06	3.6e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PIK3CD—malignant glioma	2.19e-06	3.57e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PPARG—malignant glioma	2.17e-06	3.54e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PTEN—malignant glioma	2.16e-06	3.52e-05	CbGpPWpGaD
Cisplatin—XDH—Metabolism—PIK3CA—malignant glioma	2.16e-06	3.51e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PPARG—malignant glioma	2.15e-06	3.5e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—BAD—malignant glioma	2.12e-06	3.45e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—NOTCH1—malignant glioma	2.1e-06	3.41e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—BCHE—malignant glioma	2.09e-06	3.41e-05	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—PIK3CA—malignant glioma	2.07e-06	3.37e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—SLC5A5—malignant glioma	2.07e-06	3.37e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CD80—malignant glioma	2.05e-06	3.34e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—APC—malignant glioma	2.05e-06	3.34e-05	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	2.04e-06	3.32e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—EGF—malignant glioma	2.03e-06	3.3e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—AKT1—malignant glioma	2.02e-06	3.28e-05	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—AKT1—malignant glioma	2.02e-06	3.28e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PTPN11—malignant glioma	2.01e-06	3.28e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PIK3CD—malignant glioma	1.98e-06	3.22e-05	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—AKT1—malignant glioma	1.97e-06	3.2e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PIK3CD—malignant glioma	1.96e-06	3.19e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.96e-06	3.18e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.94e-06	3.15e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—BRAF—malignant glioma	1.93e-06	3.14e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PIK3CB—malignant glioma	1.91e-06	3.11e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PTGS2—malignant glioma	1.89e-06	3.08e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—CAV1—malignant glioma	1.89e-06	3.07e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—AKT2—malignant glioma	1.88e-06	3.05e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—CAV1—malignant glioma	1.81e-06	2.95e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PIK3CD—malignant glioma	1.8e-06	2.93e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.8e-06	2.93e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PIK3CA—malignant glioma	1.79e-06	2.92e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—GSTP1—malignant glioma	1.78e-06	2.9e-05	CbGpPWpGaD
Cisplatin—XDH—Metabolism—AKT1—malignant glioma	1.76e-06	2.87e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CAT—malignant glioma	1.74e-06	2.83e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—FGF2—malignant glioma	1.73e-06	2.81e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PIK3CB—malignant glioma	1.73e-06	2.81e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PIK3CG—malignant glioma	1.72e-06	2.79e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PTGS2—malignant glioma	1.71e-06	2.78e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PIK3CB—malignant glioma	1.71e-06	2.78e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PTGS2—malignant glioma	1.69e-06	2.75e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.69e-06	2.75e-05	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—AKT1—malignant glioma	1.69e-06	2.75e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GSTP1—malignant glioma	1.67e-06	2.71e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PPARG—malignant glioma	1.66e-06	2.7e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PTEN—malignant glioma	1.65e-06	2.69e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PIK3CG—malignant glioma	1.65e-06	2.69e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—NCOR1—malignant glioma	1.64e-06	2.67e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CAT—malignant glioma	1.62e-06	2.64e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—MDM2—malignant glioma	1.61e-06	2.63e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—RAF1—malignant glioma	1.61e-06	2.62e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PPARG—malignant glioma	1.59e-06	2.59e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—ERBB2—malignant glioma	1.59e-06	2.59e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PIK3CB—malignant glioma	1.57e-06	2.56e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—NCOR1—malignant glioma	1.53e-06	2.49e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PIK3CA—malignant glioma	1.53e-06	2.48e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PIK3CD—malignant glioma	1.51e-06	2.46e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PTEN—malignant glioma	1.49e-06	2.43e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PTEN—malignant glioma	1.48e-06	2.4e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—AKT1—malignant glioma	1.47e-06	2.38e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PIK3CD—malignant glioma	1.45e-06	2.36e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PTEN—malignant glioma	1.36e-06	2.21e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CAV1—malignant glioma	1.34e-06	2.17e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PIK3CB—malignant glioma	1.32e-06	2.14e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PIK3CB—malignant glioma	1.26e-06	2.06e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PTGS2—malignant glioma	1.25e-06	2.04e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CAV1—malignant glioma	1.25e-06	2.03e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—AKT1—malignant glioma	1.25e-06	2.03e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PIK3CG—malignant glioma	1.22e-06	1.98e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—STAT3—malignant glioma	1.21e-06	1.98e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.19e-06	1.94e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PPARG—malignant glioma	1.17e-06	1.91e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PIK3CA—malignant glioma	1.17e-06	1.9e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PIK3CG—malignant glioma	1.14e-06	1.85e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PTEN—malignant glioma	1.14e-06	1.85e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—MYC—malignant glioma	1.13e-06	1.84e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—EGFR—malignant glioma	1.1e-06	1.8e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PPARG—malignant glioma	1.1e-06	1.79e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PTEN—malignant glioma	1.09e-06	1.78e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PIK3CD—malignant glioma	1.07e-06	1.74e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PIK3CA—malignant glioma	1.05e-06	1.71e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—KRAS—malignant glioma	1.04e-06	1.7e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PIK3CA—malignant glioma	1.04e-06	1.69e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PIK3CD—malignant glioma	1e-06	1.63e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PIK3CA—malignant glioma	9.58e-07	1.56e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—AKT1—malignant glioma	9.52e-07	1.55e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PIK3CB—malignant glioma	9.33e-07	1.52e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PTGS2—malignant glioma	9.24e-07	1.5e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PIK3CB—malignant glioma	8.71e-07	1.42e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PTGS2—malignant glioma	8.63e-07	1.41e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—AKT1—malignant glioma	8.59e-07	1.4e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—AKT1—malignant glioma	8.5e-07	1.38e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PTEN—malignant glioma	8.06e-07	1.31e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PIK3CA—malignant glioma	8.02e-07	1.31e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—AKT1—malignant glioma	7.82e-07	1.27e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PIK3CA—malignant glioma	7.71e-07	1.25e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PTEN—malignant glioma	7.53e-07	1.23e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—AKT1—malignant glioma	6.55e-07	1.07e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—AKT1—malignant glioma	6.3e-07	1.02e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PIK3CA—malignant glioma	5.69e-07	9.25e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PIK3CA—malignant glioma	5.31e-07	8.64e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—AKT1—malignant glioma	4.65e-07	7.56e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—AKT1—malignant glioma	4.34e-07	7.06e-06	CbGpPWpGaD
